商品信息
联系客服
郑重提醒：
无质量问题不接受退换货，下单前请仔细核对信息。
下单后请及时联系客服核对商品价格，订单生效后再付款。
GenWay/Bordetella pertussis IgM/GWB-21BFFD/1x96 Assays
免费咨询热线
4000-520-616
Description:
PleaseclickhereforMSDSPDFDatasheetProductName:BordetellapertussisIgMELISA
#ofSamples:1x96Assays
IntendedUse:TheBordetellapertussisIgM-ELISAisintendedforthequalitativedeterminationofIgMclassantibodiesagainstBordetellapertussisandBordetellapertussistoxininhumanserumorplasma(citrate).
Introduction:Bordetellaspeciesarenon-spore-formingencapsulatedbipolar,coccoid(pale-staining)Gram-negativebacilli(about0.3-0.5μmthickand1μmlong).ThegenusconsistsofthehumanparasitesB.pertussisandB.parapertussis,andB.bronchisepticaandB.aviumwhichcauseenzooticinfectionsinvariouswildanddomesticanimalspecies.B.pertussisistheclassicalexciterofpertussisandexistsonlyinillpeople;B.parapertussiscauses5-20%ofamilderandoftenclinicalunapparentformofpertussis.B.bronchisepticahasseldomly(egclosecontactwithanimals)humanpathogenicsignificanceasopportuNISTicsecondaryexciterinmixedinfections(bronchitis,pneumonia,woundinfection).
Pertussisorwhoopingcoughisabacterialinfectionoftherespiratorysystem.Itisahighlycontagiouschildhooddiseasewhichappearsseldomlyunderadults.Itistransmittedbyrespiratorycontact.B.pertussishastheABIlitytosticktotheciliaoftheepidermalcellsoftherespiratorysystem.Fragmentsofthebacterialcellwall(ExoToxin=trachealCytotoxine,TCT)inhibitthemovementoftheciliainthetrachealmucosa.Afteranincubationtimeofonetothreeweeksthediseaserunsthroughthreestages(s.tablebelow).Thelethalityis0.6%andconcernsbabiesinthefirstsixmonthswithmorethan70%.Fornewbornandprematureinfantsitishigher(1-2%).InAfricabesidemeaslevirusB.pertussisisthemainreasonforhighinfantmortility.Thedistributionofthediseaseisworldwide.
Clinicalpertussisisfollowedbynaturalacquiredimmunitywhichislong-lastingbutnotpermanent.Inmostcountriesanactivevaccinationisrecommendedwhichleadsto90%protectionforthreetotwelveyears.Usuallytheimmunizationpreparationiscombinedwithdiphtheriaandtetanustoxoids.
Thepresenceofbacteriumresp.infectionmaybeidentifiedby
Microscopy:identificationoncultures,IF
SEROlogy:DetectionofantibodyproductionbyELISA
Precisediagnosisisneededforeffectivetreatmentofpatients,forisolationofunvaccinatedinfantsatrisk,andfordifferentiationofpertussisfromatypicaldiseasesandchronicinfections.
Principlesoftheassay:ThequalitativeimmunoenzymaticdeterminationofIgM-classantibodiesagainstBordetellapertussisisbasedontheELISA(Enzyme-linkedImmunosorbentAssay)technique.
MicrotiterstripwellsareprecoatedwithBordetellapertussis/toxinantigenstobindcorrespondingantibodiesofthespecimen.AfterwashingthewellstoremoveallunboundsamplematerialhorserADIshperoxidase(HRP)labelledanti-humanIgMconjugateisadded.ThisconjugatebindstothecapturedBordetellapertussis/toxinspecificantibodies.Theimmunecomplexformedbytheboundconjugateisvisualizedbyaddingtetramethylbenzidine(TMB)substratewhichgivesabluereactionproduct.TheintensityofthisproductisproportionaltotheamountofBordetellapertussis/toxinspecificIgMantibodiesinthespecimen.Sulphuricacidisaddedtostopthereaction.Thisproducesayellowendpointcolour.Absorbanceat450nmisreadusinganELISAmicrowellplatereader.
StorageandStability:Thereagentsarestableuptotheexpirydatestatedonthelabelwhenstoredat2 8°C.
LimitationsoftheTest:Bacterialcontaminationorrepeatedfreeze-thawcyclesofthespecimenmayaffecttheabsorbancevalues.Diagnosisofaninfectiousdiseaseshouldnotbeestablishedonthebasisofasingletestresult.Aprecisediagnosisshouldtakeintoconsiderationclinicalhistory,symptomatologyaswellasserologicaldata.
Inimmunsuppremizedpatientsandnewbornsserologicaldataonlyhaverestrictedvalue
ReferencesWong,K.H.,andS.K.Skelton.1989.PreparationoffilamentoushemagglutininfromBordetellapertussisandassayforserumantibodiestofilamentoushemagglutininandpertussistoxinforclinicalandpublichealthlab.J.Clin.Microbiol.27:2805-2810Zackrission,G.,I.,Krantz,T.Legergard,P.Larsson,R.Sekura,N.Sigurs,J.Taranger,andB.Trollfors.1988.HumoralantibodyresponsetopertussistoxininpatientswithclinicalpertussisZachrisson,G.,I.Krantz,T.Lagergard,P.Larsson,R.Sekura,NSigurs,S.Taranger,andB.Trollfors.1988.Humoralantibodyresponsetopertussistoxininpatientwithclinicalpertussismeasuredbyanenzyme-linkedimmunosorbentassay.Eur.J.Clin.Microbiol.7:149-154Granstrom,M.,G.Granstrom,A.Lindtors1982.Serologicdiagnosisofwhoopingcoughbyanenzyme-linkedimmunsorbentassayusingfimbrialhemagglutininasantigen.J.Infect.Dis.146:741-745Wong,K.H.,andS.K.Skelton.1989.PreparationoffilamentoushemagglutininfromBordetellapertussisandassayforserumantibodiestofilamentoushemagglutininandpertussistoxinforclinicalandpublichealthlab.J.Clin.Microbiol.27:2805-2810Zackrission,G.,I.,Krantz,T.Legergard,P.Larsson,R.Sekura,N.Sigurs,J.Taranger,andB.Trollfors.1988.HumoralantibodyresponsetopertussistoxininpatientswithclinicalpertussisZachrisson,G.,I.Krantz,T.Lagergard,P.Larsson,R.Sekura,NSigurs,S.Taranger,andB.Trollfors.1988.Humoralantibodyresponsetopertussistoxininpatientwithclinicalpertussismeasuredbyanenzyme-linkedimmunosorbentassay.Eur.J.Clin.Microbiol.7:149-154Granstrom,M.,G.Granstrom,A.Lindtors1982.Serologicdiagnosisofwhoopingcoughbyanenzyme-linkedimmunsorbentassayusingfimbrialhemagglutininasantigen.J.Infect.Dis.146:741-745
AdditionalInformation:
| Name | BordetellapertussisIgM |
|---|---|
| RelatedProductNames | BordetellapertussisIgM–ELISA |
| MolecularWeight | 0.5 |
| Storage | Thereagentsarestableuptotheexpirydatestatedonthelabelwhenstoredat2 8°C. |
| IntendedUse | ResearchUseOnly |
